After Eprex® discontinuation: Multicenter evidence for a biosimilar erythropoietin and health system resilience in Taiwan

Journal of the Chinese Medical Association 2026 Open access

Read full text

Authors: Chih‐Yu Yang

DOI: 10.1097/jcma.0000000000001362

Cited by: 0

References: 8

Fields of Study & Subjects

Biosimilars and Bioanalytical Methods Erythropoietin and Anemia Treatment Pharmaceutical Economics and Policy

References 8